This is the authors' abstract. We don't add key points for this paper.
Immunoglobulin (Ig)G4-related disease (IgG4-RD) is a systemic, chronic inflammatory disorder that was established in Japan this century. IgG4-related dacryoadenitis and sialadenitis, also known as Mikulicz's disease, and type 1 autoimmune pancreatitis are representative IgG4-RDs. The pathology can cause irreversible dysfunction in the kidneys, lungs, retroperitoneal cavity, thyroid gland, and prostate gland [1]. For this reason, early therapeutic intervention is necessary [2]. Diagnosis is therefore very important. For this purpose, the comprehensive diagnostic criteria for IgG4-RD, developed in 2011 [3], and the clinical diagnostic criteria for specific organ involvements of IgG4-RD can be used [4–8]. The comprehensive diagnostic criteria consist of enlargement of the involved organs, elevated levels of serum IgG4, and marked infiltration of IgG4-bearing plasmacytes into the involved organs. We can diagnose cases satisfying all these criteria as “definite” IgG4-RD. When only physical/imaging findings and histopathological findings are satisfied, the case is defined as “probable’ IgG4-RD.” Cases with physical/imaging findings and serological findings represent “possible” IgG4-RD. Four years have passed since the comprehensive diagnostic criteria were established, and they have been confirmed as useful for the diagnosis of IgG4-RD. However, no validation of the criteria has been performed. We therefore validated the 2011 comprehensive diagnostic criteria for IgG4-RD using a SMART (Sapporo Medical University and related institutes database for investigation and best treatment for IgG4-RD) registry cohort [9].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: